In exam rooms across Boston, clinicians are increasingly confronting a scenario they used to see mostly in older patients: young adults being told they have colorectal cancer, often after the disease has already spread.
One of those patients is 33-year-old John Veale, who went to the doctor last summer after noticing blood in his stool. By the time the tests were done, Veale was staring down a stage four diagnosis. His whirlwind path from shock to treatment, including enrolling in a clinical trial, was chronicled in local reporting. As reported by WHDH, Veale said the news "almost feels like a bullet through your heart," and his oncologist cautioned that many of the younger patients now filling clinics do not have the traditional risk factors doctors were taught to look for.
Dana-Farber Builds A Clinic Around Young Patients
Boston is not just seeing the problem, it is trying to study it in real time. At Dana-Farber, physicians have created one of the country’s first clinics devoted specifically to younger colorectal cancer patients. The Young-Onset Colorectal Cancer Center, led by founding director Dr. Kimmie Ng, is set up to both deliver day-to-day care and dig into why this is happening, according to Dana-Farber.
The center is investigating possible drivers such as changes in the gut microbiome and offering targeted clinical trials designed with younger adults in mind. It also provides psychosocial support that acknowledges the particular upheaval a cancer diagnosis can cause when people are in the middle of building careers, families, or both.
Nationwide Numbers Show A Steady Climb
The trend is not limited to Boston. National data confirm that colorectal cancer in younger adults has been creeping upward for years and is reshaping who bears the brunt of the disease. The American Cancer Society’s Cancer Facts & Figures 2024 reports roughly a 2.4% annual increase in incidence among people younger than 50 between 2012 and 2021, and notes that colorectal cancer has become a leading cause of cancer death in younger adults, according to the American Cancer Society.
For patients and doctors, that translates into more people in what used to be considered the “too young for this” category suddenly finding themselves in oncology waiting rooms.
What Scientists Are Looking At
Researchers say there is no single smoking-gun explanation on the table. Instead, multiple suspects are under investigation, including diet, alcohol use, sedentary lifestyles, and shifts in the gut microbiome. Academic reviews and large epidemiologic analyses point to a birth-cohort effect and show faster increases in cases among the very youngest adults. That pattern suggests a mix of environmental and biological influences rather than a lone culprit, according to a review in PubMed Central.
For now, the science is still catching up to the clinic, which means prevention and early detection remain the biggest levers available.
Screening, Red-Flag Symptoms, And Next Steps
On the prevention front, the U.S. Preventive Services Task Force recommends routine colorectal cancer screening for average-risk adults starting at age 45. Acceptable options range from annual fecal immunochemical tests to colonoscopy, according to the USPSTF.
Public health guidance also stresses that certain symptoms should never be brushed off as “just something I ate.” Any rectal bleeding, persistent abdominal pain, unexplained weight loss, or prolonged changes in bowel habits should prompt immediate medical evaluation, per the CDC.
Back in Boston, Veale says there are signs his grueling treatment is making a difference. After eight months of therapy, his scans showed tumor shrinkage. Clinicians caution that stories like his underline a bigger reality: meaningful prevention depends heavily on awareness and access to care.
According to Dana-Farber, its young-onset programs and clinical trials are expanding in an effort to catch cancers earlier and tailor treatment to younger patients. Local doctors are urging anyone with a family history or persistent symptoms to talk with a primary care provider about whether earlier or more frequent screening makes sense.
